BIOCORNEUM Joins Bioderma Portfolio

Nuance Medical announced the successful acquisition of BIOCORNEUM, a silicone gel scar treatment brand previously owned by Sientra, according to a press release. Effective immediately, BIOCORNEUM will become a part of the Biodermis portfolio, Nuance Medical’s brand specializing in silicone scar management products.

“Bringing BIOCORNEUM into the Biodermis family marks a significant step in our journey to lead with innovative and impactful treatments in scar management," said Mark Steele, President of Nuance Medical. "This acquisition integrates BIOCORNEUM’s strong presence in the professional healthcare sector with Biodermis’ comprehensive range of silicone scar management products. We are excited about the combined capabilities this brings and the enhanced benefits it offers to our healthcare partners and their patients.”

In order to facilitate a smooth transition and continuous support, BIOCORNEUM customers are asked to contact Biodermis directly for placing orders or inquiries at 800-322-3729 or via email at orders@biodermis.com. In addition, a dedicated webpage with frequently asked questions for BIOCORNEUM customers can be found at: https://www.biodermis.com/pages/biocorneum-customer-faqs.